← Open Payments lookup

NATALIE WONG: Open Payments

NPI 1619751930 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,959 in 191 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,038 · 2025 $5,959

Food & beverage: $5,959
CompanyPaymentsAmount
ABBVIE INC.27$820
Vanda Pharmaceuticals Inc.25$789
Otsuka America Pharmaceutical, Inc.21$643
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$501
E.R. Squibb & Sons, L.L.C.19$489
Janssen Pharmaceuticals, Inc9$423
Neurocrine BioSciences, Inc.15$400
Axsome Therapeutics, Inc.9$334
Biogen, Inc.9$306
Teva Pharmaceuticals USA, Inc.16$305

Products named: VRAYLAR, FANAPT, CAPLYTA, COBENFY, REXULTI, INGREZZA, Auvelity, ZURZUVAE.

Industry payments across CA — which companies pay providers there.